Zura Bio (NASDAQ:ZURA) Stock Price & Analysis

–

USD

–(–)

Open

$5.23

Prev. Close

$5.38

High

$5.41

Low

$5.025

Company Profile

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

CEOSandeep C. Kulkarni

SectorHealthcare

IndustryBiotechnology

Employees40

IPO DateMar 21, 2023

ExchangeNASDAQ

Exchange NameNASDAQ Capital Market

CurrencyUSD

Headquarters & Contact

Address1489 W. Warm Springs Road

City / State / ZIPHenderson, NV, 89014

CountryUnited States

Phone858 247 0520

Websitehttps://zurabio.com

Zura Bio Limited

Company Profile

Recently from Cashu